ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,488,000 | -45.0% | 217,328 | 0.0% | 0.02% | -40.5% |
| Q1 2017 | $4,520,000 | 0.0% | 217,328 | 0.0% | 0.04% | -15.9% |
| Q4 2016 | $4,520,000 | -36.5% | 217,328 | 0.0% | 0.04% | -32.3% |
| Q3 2016 | $7,122,000 | +31.2% | 217,328 | 0.0% | 0.06% | +14.0% |
| Q2 2016 | $5,427,000 | -67.7% | 217,328 | -57.7% | 0.06% | -63.2% |
| Q3 2015 | $16,820,000 | -64.4% | 513,439 | -42.4% | 0.16% | -62.6% |
| Q2 2015 | $47,233,000 | +86.1% | 891,688 | +1.4% | 0.41% | +96.2% |
| Q1 2015 | $25,385,000 | +469.0% | 879,581 | +473.6% | 0.21% | +358.7% |
| Q4 2014 | $4,461,000 | +129.5% | 153,350 | 0.0% | 0.05% | +91.7% |
| Q3 2014 | $1,944,000 | -36.8% | 153,350 | 0.0% | 0.02% | -36.8% |
| Q2 2014 | $3,078,000 | – | 153,350 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |